Dulaglutide and Type 2 Diabetes

WEBINAR: Tuesday 10 August 2021, 7.30 - 9.00 pm

Dulaglutide, a subcutaneous once-weekly GLP-1 receptor agonist, will be available fully funded by Special Authority as soon as it is approved by Medsafe.

In this webinar, Dr Paul Ryan diabetologist and endocrinologist overviews the role of dulaglutide in diabetes management.

Key topics include:

Type 2 diabetes: New treatment on the horizon

WEBINAR ARCHIVE: Dr Ole Schmiedel discusses a New Zealand centric context for best practice in diabetes management inclusive of new therapies.

Obesity and risk in COVID-19

WEBINAR 14 July: Obesity and risk in COVID-19 with Rinki Murphy

Type II diabetes in young people

View archived webinar: Dr Steven Miller, Consultant Physician in Endocrinology and Diabetes at North Shore Hospital, Auckland discusses type II diabetes in young people in NZ.

Osteoporosis update - Ian Reid

Distinguished Professor Ian Reid talks about Osteoporosis New Zealand's Guidance on Diagnosing and Managing Osteoporosis in New Zealand.

Osteoporosis with Prof Ian Reid

2015: Professor Ian Reid an international expert on bone disease, discusses the latest on osteoporosis. Ian is a Professor of Medicine and Endocrinology at the University of Auckland and an international expert and research award winner in osteoporosis.

Subscribe to Endocrinology